(20 second reading) Divi’s Laboratories is planning to expand its capacity at its manufacturing facilicity with an estimated investment of up to Rs.700 crore & s estimated to be operational around January 2027.
It added that the same would be funded via internal accruals.
Divi’s Laboratories said it could not disclose any further details because of the confidentiality agreement it had signed with the customer.
The pharma major reported a 17% year-on-year increase in its net profit to Rs 358 crore for the third quarter of the 2023-24 fiscal year.